With the advent of increased globalisation of clinical trials, all stakeholders have adopted greater reliance on outsourced translations. Translations have become an essential link in the chain of development when successfully launching global products. Valerie Thorpe at Transcom explains that for any product that is propelled onto the global life-science stage, the pathway invariably includes conducting clinical study translations which must meet stringent local requirements in all of the countries where the clinical trial is conducted.